• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[膀胱P-1期原发性肿瘤。对使用阿霉素和丝裂霉素C预防复发所获结果的批判性评估]

[Stage P-1 primary neoplasia of the bladder. Critical evaluation of results obtained with the use of adriamycin and mitomycin C in the prevention of recurrences].

作者信息

Liberti M, Tenaglia R, De Berardinis E, Gentile V

出版信息

Minerva Med. 1984 Feb 28;75(8):391-4.

PMID:6424059
Abstract

However adequately treated, surface carcinomas of the bladder recur sooner or later with infiltration found in about 10% of cases. Any development that may offer therapeutic progress and reduce the incidence of recurrences is therefore of primary importance. Two homogeneous groups of patients were selected for the present study: 35 were given Adriamycin and 25 Mitomycin C. In evaluating results, the incidence of recurrences in relation to the primary neoplasia and the existence of single or multiple tumors was analysed. It is concluded that Mitomycin C in association with either T.U.R. or T.V.R. is a particularly useful and indubitably effective form of topical chemotherapy in cases of single or multiple primary neoplasias.

摘要

无论治疗多么充分,膀胱表浅癌迟早会复发,约10%的病例会出现浸润。因此,任何可能带来治疗进展并降低复发率的进展都至关重要。本研究选取了两组同质患者:35例给予阿霉素,25例给予丝裂霉素C。在评估结果时,分析了与原发性肿瘤相关的复发率以及单发或多发肿瘤的存在情况。得出的结论是,丝裂霉素C联合经尿道切除术(T.U.R.)或经尿道汽化术(T.V.R.)是治疗单发或多发原发性肿瘤时一种特别有用且无疑有效的局部化疗方式。

相似文献

1
[Stage P-1 primary neoplasia of the bladder. Critical evaluation of results obtained with the use of adriamycin and mitomycin C in the prevention of recurrences].[膀胱P-1期原发性肿瘤。对使用阿霉素和丝裂霉素C预防复发所获结果的批判性评估]
Minerva Med. 1984 Feb 28;75(8):391-4.
2
Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
Prog Clin Biol Res. 1988;269:525-37.
3
[Can topical chemoprevention modify the rate of recurrence and progression of superficial bladder cancer?].[局部化学预防能否改变浅表性膀胱癌的复发率和进展速度?]
Urologe A. 1988 May;27(3):147-51.
4
[Intravesical mitomycin for superficial tumors of the bladder: difficulties of cystoscopic monitoring].膀胱内注射丝裂霉素治疗膀胱浅表肿瘤:膀胱镜监测的难点
Ann Urol (Paris). 1988;22(6):404-6.
5
[Intravesical chemical prevention of recurrence of superficial urothelial bladder cancer. Progress report of the Urology Clinic of Mainz University 1975-1981].[膀胱内化学预防浅表性膀胱尿路上皮癌复发。美因茨大学泌尿外科诊所1975 - 1981年进展报告]
Helv Chir Acta. 1982 Aug;49(3-4):345-8.
6
[Local mitomycin-C therapy of infiltrating bladder cancer].[浸润性膀胱癌的局部丝裂霉素 C 治疗]
Fortschr Med. 1984 Aug 16;102(29-30):767-71.
7
Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.荷兰合作试验最新情况:丝裂霉素与卡介苗-蒂策株菌对比卡介苗-荷兰国家公共卫生与环境研究所菌株治疗pTA-pT1期乳头状癌及膀胱原位癌患者。荷兰东南部合作泌尿外科组
Semin Urol Oncol. 1996 Feb;14(1 Suppl 1):10-6.
8
Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup.单次即刻膀胱灌注丝裂霉素C治疗低危浅表性膀胱癌患者的疗效:短期和长期随访
J Urol. 1999 Apr;161(4):1120-3.
9
[Intravesical chemical prevention of recurrence. A randomized animal experimental study].[膀胱内化学预防复发。一项随机动物实验研究]
Helv Chir Acta. 1982 Aug;49(3-4):353-6.
10
Therapeutic use of mitomycin C in bladder cancer.丝裂霉素C在膀胱癌中的治疗应用。
Prog Clin Biol Res. 1984;162B:113-22.